The Regents will be discussing two health-related items in open session on Nov. 17. Item H1 describes what is happening in the use of AI in providing health services. Item P1 describes UC's health/medical-related perspective on providing such services to the San Joaquin Valley (the region of UC-Merced). I asked Claude to pretend it was a regent and develop questions that should be raised given these documents. It seemed reasonable, given the topic of H1. Below is Claude's response:
Regent's Report on Health Items for the November 17, 2026 Meeting
Items H1 (Health Services Committee) and P1 (Public Engagement and Development Committee)
Both items are discussion items with no action requested. Both describe what UC is already doing and where it wants to go, but neither includes a budget, a timeline with milestones, or measures of success. Most of my questions aim to fill those gaps before the Board is asked to commit money or approve anything.
Item H1: Artificial Intelligence in Health: Strategic Priorities, Collaboration, and Emerging Issues
What the item says. AI is becoming part of how clinical care, operations and research work at UC's six academic health centers. The item cites these uses:
- ambient AI scribes and AI-drafted replies to patient messages, which reduce documentation work and burnout
- research uses, such as predicting preterm birth and flagging patients with an undiagnosed immune disorder
- AI training for the more than 19,000 students and residents in UC's 21 health schools
The item names three guiding themes: AI should support clinical care rather than replace it, it should be deployed safely and equitably, and it should advance UC's mission. Governance differs from one center to another, but all of them use multidisciplinary review, include nurses on review committees, monitor tools after deployment, test them for bias, and follow data-stewardship rules.
The item gives these examples of industry partnerships: Optum Labs (machine learning for personalized therapy and for cost and quality of care), GE HealthCare (AI-assisted imaging), and ARPA-H's ADVOCATE program (AI agents for cardiovascular care, supervised by a separate AI system). The Center for Data-driven Insights and Innovation (CDI2) manages harmonized health records from all six centers, which the item calls UC Health's "unique business asset." For example, CDI2 data supported a lung-disease model trained on more than 200,000 patients. A systemwide AI for Health conference is planned for early 2027.
Questions I would ask
Money and value
- How much is UC Health spending on AI each year, including licenses, staff, computing and monitoring, at each center and systemwide? What return have we measured so far, in dollars, clinician time saved, or patient outcomes?
- Ambient scribes are the leading example. When documentation becomes more thorough, billing codes often rise. Have the scribes changed coding intensity or revenue? How are we making sure AI-assisted documentation cannot be seen as upcoding, especially in Medicare and Medi-Cal?
- If AI saves clinicians time, who gets that time back? Will it go to patients and clinician well-being, or will it turn into higher productivity quotas? Have the nurses' and physicians' unions been consulted on this?
Patients, safety and accountability
- Are patients told when an AI scribe is recording their visit or when AI drafted a message they receive? Can they opt out, and how many do?
- When an AI-assisted decision harms a patient, who is responsible: the clinician, the health center, or the vendor? Do our vendor contracts allocate that liability, and have our malpractice carriers or self-insurance programs changed premiums or coverage?
- The item mentions post-deployment monitoring, such as UCSF's continuous-monitoring platform. Is monitoring required for every clinical AI tool at every center, or only some? Have any tools been pulled or changed because of monitoring results? Please give examples.
- Does the Board receive a report of AI-related safety events or near misses, as it does for other quality and safety measures? If not, should it?
- About half of patients in parts of our service areas speak a language other than English at home. How well do the scribes and message tools work in Spanish and other languages, and in conversations that switch between languages?
Data and industry partners
- The item calls the systemwide patient data a "business asset." Under what terms does industry gain access to it? Is UC paid for that access or does it receive equity, and how are the patients whose data was used informed or represented?
- Optum is part of UnitedHealth Group, a major insurer that also owns physician groups competing with UC. What firewalls keep insights from UC patient data from being used against UC or its patients in pricing, contracting or competition?
- Even de-identified data can sometimes be traced back to individuals. How do we manage that risk when we share data with AI developers? Have there been any security incidents involving AI tools or vendors?
- Six centers each choosing their own vendors means duplicated contracts and the risk of being locked into one vendor. Is any purchasing or vetting done systemwide, and what more should be centralized?
- Federal and state rules on health AI are changing, including FDA oversight, CMS rules and California laws on AI in patient communications and utilization review. How do we track compliance, and what is UC advocating for?
Education and the workforce
- The item raises a concern that relying on AI could keep learners from building their own clinical reasoning. Is the proposed fix (reason first, then check with AI, and assess with and without AI) required in every UC medical school, or only recommended? How will we know whether our graduates' independent reasoning holds up?
- What are the plans for AI training for the current workforce, including nurses, pharmacists and staff, not just students?
- Could AI tools such as remote monitoring, e-consults and translation help UC reach underserved regions like the San Joaquin Valley (Item P1)? Is anyone coordinating the two efforts?
Item P1: Building a Physician Workforce and Healthier Communities in the San Joaquin Valley
What the item says. The San Joaquin Valley has more than four million residents, and its population is projected to grow over the next decade at more than twice the state rate. The region faces these gaps:
- 85% of residents live in primary care shortage areas.
- The region has 68.8 primary care physicians per 100,000 residents, compared with 98.8 statewide.
- It has 86.6 specialists per 100,000, compared with 177 statewide.
- Rates of diabetes, hypertension and heart disease are higher, and life expectancy is lower, than state averages.
UC's response has built up over time:
- UCSF Fresno opened in 1975. About 40% of its residency and fellowship graduates practice in the Valley and 70% stay in California.
- The Regents endorsed medical education planning at UC Merced in 2008.
- SJV PRIME began in 2011.
- SJV PRIME+ began in 2023. It is an eight-year B.S.-to-M.D. pathway with UC Merced, the UCSF School of Medicine and UCSF Fresno. Its first cohort starts medical school in 2027 and graduates with UCSF M.D. degrees in 2031.
The stated goal is an independently accredited medical school at UC Merced, which would be UC's seventh. UCSF would serve as "sponsor and mentor" during the transition, and enrollment would grow from about 12 to about 50 students a year. The new Medical Education Building is finished, and the item names Community Medical Centers, Valley Children's, the VA and United Health Centers as clinical partners.
Questions I would ask
Cost, funding and timeline
- What is the full cost of reaching independent accreditation, both one-time and ongoing, and where will the money come from: state appropriations, UC Merced's core budget, UCOP, UCSF, clinical partners or philanthropy? Because this item went to the Public Engagement and Development Committee, what is the fundraising goal, and has a lead donor been identified?
- What is the timeline, with milestones, for applying to the accrediting body (LCME), reaching preliminary and full accreditation, and growing from 12 to 50 students? Which milestones would come back to the Regents for approval?
- UC Riverside's medical school, UC's most recent, faced serious money problems in its early years. What lessons from Riverside are built into this plan, and what is the fallback if state funding does not come through?
- Medicaid cuts under the 2025 federal budget law hit regions with heavy Medi-Cal enrollment, like the Valley. How will they affect the finances of our clinical partners and their ability to host students and residents?
Will it actually produce Valley physicians?
- Doctors tend to practice near where they did their residency, not their medical school. How many new residency positions in the Valley are planned and funded to go with the larger class? Without them, will we be training doctors for other regions?
- About 40% of UCSF Fresno's residency graduates stay in the Valley. What is the rate for SJV PRIME graduates since 2011? What target will define success for the Merced school, and how will we track graduates over time?
- How many graduates go into primary care, psychiatry and other specialties in shortest supply, compared with higher-paying specialties? Could tuition support or loan forgiveness tied to Valley practice make a difference?
- About 50 graduates a year is a small number for a region of four million people that is short thousands of physicians. What other steps (residency positions, nurse practitioners and physician assistants, telehealth, partnerships with community clinics) belong in the same strategy?
Structure and governance
- UC has no academic medical center of its own in the Valley. Can an accredited medical school rely entirely on affiliated hospitals over the long term? Is UC considering acquiring or building a hospital or clinics in the region, and what would that cost and risk?
- What happens to UCSF Fresno once Merced becomes independent? Does it stay with UCSF, move to Merced, or become a shared entity? Has UCSF agreed to that arrangement, and what does UCSF get out of it?
- How will Merced recruit and keep clinical faculty in a region that is already short of physicians, without pulling doctors away from patient care?
- Admissions would favor applicants committed to the region, "consistent with applicable nondiscrimination law." Given Proposition 209 and current federal scrutiny of admissions, has the General Counsel reviewed the criteria? How will commitment be measured in a way that holds up legally?
- What happens to UC Merced's other priorities, such as undergraduate growth and research, as campus resources go to the medical school?
- Other medical schools are already in the region, such as the osteopathic school at California Health Sciences University in Clovis. Will a UC Merced school compete with them for clinical training sites, or cooperate with them?
Questions that apply to both items
- Both items describe UC Health's public mission. Could the Board receive a single set of measures, covering access, quality, equity, workforce and financial results, that tracks progress on both items over time?
- When will each item come back to the Board, and in what form: an update, a budget request, or an action item?
Prepared from the November 17, 2026 Regents agenda materials for Items H1 and P1.
===
Who knows? Maybe one or more Regents will have consulted an AI program before the session. Or maybe not.

No comments:
Post a Comment
Note: Only a member of this blog may post a comment.